Log In
BCIQ
Print this Print this
 

Anaplastic lymphoma kinase (ALK)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Anaplastic lymphoma kinase (ALK)

BCIQ
Print ChartPrint this
Marketed, 3 Phase II, 2 Phase I/II, 3 Phase I, 4
Phase of DevelopmentPhase IPhase I/IIPhase IIMarketed
Cancer

4

3

2

3




 Products Targeting Anaplastic lymphoma kinase (ALK)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

13

$2,878.4M

$1.4M

$27.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today